Senegal
A $45 million investment has been announced to support vaccine production in Senegal.
The U.S. Development Finance Corporation (DFC), the African Development Bank (AfDB), and the International Finance Corporation (IFC) have joined forces to fund VaxSen, the vaccine production and distribution arm of the Pasteur Institute in Dakar.
The agreement, signed on December 13th in the presence of Senegalese President Bassirou Diomaye Faye, underscores Senegal's leadership in advancing public health goals across the continent.
The funding will enhance local vaccine production, strengthen supply chains, and establish a solid network for vaccine distribution.
This aligns with the African Union’s Vision 2040, which aims for Africa to locally produce 60% of its vaccine needs.
Go to video
European and African leaders gather in Angola for EU-AU summit
Go to video
UNICEF secures agreement to cut malaria vaccine costs
01:03
Caribbean delegation seeks justice for slavery in Britain
11:16
Côte d’Ivoire: a growing economy despite inequalities [Business Africa]
01:54
UN and AU deepen partnership to synchronize agendas and end continent's conflicts
00:47
African Union says continent's rising debt crisis undermines development